Cancer Family
Mesenchymal Cell Neoplasm
CI-CAN-00000027Explore in graph →
Non-malignant413 active trials10 approved drugs208 evidence items
- NCIt
- C7059
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000027Explore in graph →
Clinical trials
1,848 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00132158 | ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid Tumors | completed | Phase 1 | 19 | St. Jude Children's Research HospitalOTHER | 1 | Apr 17, 2012 | clinicaltrials |
| NCT00436657 | Continuous Hyperthermic Peritoneal Perfusion (CHPP) With Cisplatin for Children With Peritoneal Cancer | completed | Phase 1 | 10 | M.D. Anderson Cancer CenterOTHER | 1 | Apr 2, 2012 | clinicaltrials |
| NCT01031901 | Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1) | completed | Phase 1 | 52 | The University of Texas Health Science Center, HoustonOTHER | 1 | Feb 27, 2012 | clinicaltrials |
| NCT00122473 | Imatinib in Dermatofibrosarcoma Protuberans (DFSP) | completed | Phase 1 / Phase 2 | 30 | Dermatologic Cooperative Oncology GroupOTHER | 1 | Jul 29, 2011 | clinicaltrials |
| NCT00361036 | Comparison Study in the Treatment of Uterine Fibroids Uterine Fibroid Embolization Using BeadBlock™ Embolic Agent | completed | Phase 1 | 44 | Worthington-Kirsch, Robert L., M.D.INDIV | 1 | Apr 18, 2011 | clinicaltrials |
| NCT00276302 | Safety Study of IPI-504 in Patients With Gastrointestinal Stromal Tumors (GIST) or Soft Tissue Sarcomas (STS) | completed | Phase 1 | 63 | Infinity Pharmaceuticals, Inc.INDUSTRY | 2 | Jan 6, 2011 | clinicaltrials |
| NCT00069940 | Vaccine Therapy and Sargramostim in Treating Patients With Sarcoma or Brain Tumor | completed | Phase 1 | — | Dana-Farber Cancer InstituteOTHER | 1 | Dec 28, 2010 | clinicaltrials |
| NCT00543790 | Study Evaluating PRA-027 Multiple Ascending Doses In Cycling And Postmenopausal Women | completed | Phase 1 | 48 | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Oct 28, 2010 | clinicaltrials |
| NCT00457743 | A Phase I/II Study of Sunitinib Malate (SU011248) In Patients With Gastrointestinal Stromal Tumor (GIST) | completed | Phase 1 / Phase 2 | 36 | PfizerINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00444704 | Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females | completed | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Jul 10, 2009 | clinicaltrials |
| NCT00187109 | Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide Chemotherapy | completed | Phase 1 / Phase 2 | 40 | St. Jude Children's Research HospitalOTHER | 1 | Apr 10, 2008 | clinicaltrials |
| NCT00001209 | A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal Tumors | completed | Phase 1 | 120 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00001436 | A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With Osteosarcoma | completed | Phase 1 | 24 | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2008 | clinicaltrials |
| NCT00427544 | Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential | completed | Phase 1 | — | Wyeth is now a wholly owned subsidiary of PfizerINDUSTRY | 1 | Dec 5, 2007 | clinicaltrials |
| NCT00562471 | Safety and Efficacy Study of a Hydrogel, Applied Following Removal of Myomas During Gynecologic Surgery, Administered for the Prevention/Reduction of Postoperative Adhesion Formation | completed | Phase 1 / Phase 2 | 76 | Angiotech PharmaceuticalsINDUSTRY | 3 | Nov 22, 2007 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Apr 17, 2012source: clinicaltrials